Now researchers in the former Laboratory of Chromatin Biology and Epigenetics, headed by C. David Allis until his death in early 2023, have discovered surprising new details about the mechanics of this protein complex, which could potentially lead to new cancer therapies. The findings were published in Genes & Development.
Leveraging the potential of NfL as a biomarker, researchers from Japan have developed the world’s first aptamer (tiny, single-stranded synthetic DNA molecules) that can bind NfL with high affinity and specificity
A gene called FOXJ1 may drive resistance to taxane chemotherapy during treatment for advanced prostate cancer, according to a new study led by investigators at Weill Cornell Medicine and Beth Israel Deaconess Medical Center.
Cedars-Sinai investigators working to optimize a cell-based treatment for retinitis pigmentosa have uncovered how transplanted neural stem cells interact with host retinal cells to preserve vision.
Researchers have found that targeted delivery of messenger RNA (mRNA) can restore sperm production and fertility in genetically infertile male mice.
This simple injection may one day help people recover more safely and fully after a heart attack.
Researchers at the Peter Doherty Institute for Infection and Immunity (Doherty Institute) have developed a world-first portable point-of-care test that detects four common sexually transmitted infections at once, in under an hour.
A Japanese research team has demonstrated in rat experiments that stem cells from human primary tooth pulp may help treat chronic-phase cerebral palsy.
UCLA scientists have developed a next-generation CAR-T cell therapy that can overcome the immunosuppressive tumor microenvironment, a protective shield that tumors use to weaken immune cells, block their attack, and fuel tumor growth.
A new study by researchers at Wake Forest University School of Medicine has identified a promising strategy to treat brain metastases, one of the most challenging and deadly complications of lung cancer.